Literature DB >> 28927997

Toxic epidermal necrolysis after ivermectin.

Karan Seegobin1, Emma Bueno2, Satish Maharaj2, Tracy Ashby3, Megan Brown4, Lisa Jones3.   

Abstract

Keywords:  Adverse effect; Ivermectin; Toxic epidermal necrolysis

Mesh：

Substances：

Year:  2017        PMID： 28927997     DOI： 10.1016/j.ajem.2017.09.021

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  5 in total

1.  Severe cutaneous adverse reactions associated with systemic ivermectin: A pharmacovigilance analysis.

Authors:  David Bomze; Eli Sprecher; Shamir Geller
Journal:  J Dermatol       Date:  2022-04-27       Impact factor: 3.468

Review 2.  [Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection].

Authors:  Valeria Herrera-Lasso Regás; María Teresa Dordal Culla; Ramón Lleonart Bellfill
Journal:  Med Clin (Barc)       Date:  2020-07-09       Impact factor: 1.725

3.  Ivermectin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.

Authors:  Ines Kerneuzet; Eline Blind; Laure Darrieux; Stéphanie Moreau; Gilles Safa
Journal:  JAAD Case Rep       Date:  2018-06-02

4.  Severe cutaneous adverse drug reactions manifesting as Stevens-Johnson syndrome and toxic epidermal necrolysis reported to the national pharmacovigilance center in Nigeria: a database review from 2004 to 2017.

Authors:  Kazeem Adeola Oshikoya; Ibrahim Abayomi Ogunyinka; Comfort Kunak Ogar; Abiodun Abiola; Ali Ibrahim; Ibrahim Adekunle Oreagba
Journal:  Ther Adv Drug Saf       Date:  2020-02-12

5.  Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper.

Authors:  Aslı Gelincik; Knut Brockow; Gülfem E Çelik; Inmaculada Doña; Cristobalina Mayorga; Antonino Romano; Özge Soyer; Marina Atanaskovic-Markovic; Annick Barbaud; Maria Jose Torres
Journal:  Allergy       Date:  2020-07-01       Impact factor: 14.710
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.